Psychedelic Bulletin #125: New Data Boosts Spravato’s Case; Bipartisan Breakthrough Therapies...

Psychedelic Research Bulletin: November 2022

Psychedelics Weekly – Cannabis as an Adjunct Cancer Treatment & 5-MeO-DMT...

Numinus Wellness Inc. Reports Q4 2022 and Annual Results

PsyBio Therapeutics Announces Non-Brokered Private Placement Financing

FILAMENT HEALTH ANNOUNCES NEW UNITED STATES PATENT ISSUANCES

Revive Therapeutics Ltd. Announces Offering of Up to $5 Million

Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming...

Many Trips, Diminishing Returns: Cross-Tolerance Between LSD and DOI

PT375 – Microdosing & Citizen Science: Introducing the World’s First Take-Home...

Load more